Navigation Links
Study examines benefit of follow-up CT when abdominal ultrasound inconclusive
Date:4/29/2012

About one-third of CT examinations performed following an inconclusive abdominal ultrasound examination have positive findings, according to a study of 449 patients at Massachusetts General Hospital in Boston.

Opinions vary as to the need and relevance for further diagnostic imaging workup after an inconclusive abdominal ultrasound examination, said Supriya Gupta, MD, one of the authors of the study. "Our study found that 32.9% of follow-up CT examinations had positive findings, while 42.7% had findings that were not significant and 11.7% were equivocal. The remaining 12% had incidental findings, that is, important findings but not related to the clinical indication for the exam, said Dr. Gupta.

"While only about 33% of the CT examinations had positive findings it doesn't mean that the other CT exams were not valuable as sometimes even negative exams add a lot to patient management," noted Dr. Gupta.

The study found that follow-up CT was most useful in diagnosing renal lesions. The positivity rate for CT was 87.5% for renal cysts and 81.8% for renal stone, said Dr. Gupta. Renal cysts and renal stone were two of the more common indications for recommending follow-up CT.

CT had the least value as a follow up exam for indeterminate pancreatic and intestinal masses on ultrasound, with a less than 10% positivity rate" said Dr. Gupta.

The study results emphasize that the benefits of CT as a follow-up to inconclusive ultrasound examinations need to be more carefully reviewed; standardized guidelines for the use of follow-up CT need to be developed because the use of CT has cost and radiation implications, said Dr. Gupta.

The study will be presented on April 30 at the American Roentgen Ray Society Annual Meeting in Vancouver, Canada.


'/>"/>

Contact: Samantha Schmidt
sschmidt@arrs.org
703-858-4316
American Roentgen Ray Society
Source:Eurekalert

Page: 1

Related medicine news :

1. Study Recommends Putting Your Left Face Forward
2. Blood Clot Risk for Outpatients Needs More Attention: Study
3. NYUCNs Dr. Laura Wagner: Study finds accreditation improves safety culture at nursing homes
4. Animals More Interesting to Kids Than Toys, Study Shows
5. Bullied Children at Greater Risk for Self-Harm, Study Finds
6. Study finds mammography beneficial for younger women
7. Leaded Gas Exposure Linked to Later Violence: Study
8. Poor Sleep Heightens Ringing Ear Disease Symptoms: Study
9. Pacemakers, Defibrillators Sources of Deadly Infections: Study
10. Botox Offers Little Relief for Migraine, Study Finds
11. Impulsive Tots at Risk for Gambling Problems Later: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... On Tuesday, April 26, 2016 members of the HomeTown ... of Gov. Nathan Deal on SB 258, the “Rural Health Care Relief” Bill. , ... 70% tax credit to individuals and corporations which donate directly to a “rural hospital” ...
(Date:4/29/2016)... ... April 29, 2016 , ... Conditions were ideal for ... Island Park on Sunday, with sunny skies, a light breeze and temperatures in the ... , The 5k Run and Walk and 1-mile walk were held to ...
(Date:4/29/2016)... ... 2016 , ... The Wharton School of the University ... of the 2016 Wharton Business Plan Competition —as well as the Wharton ... the Committee Award for Most ‘Wow Factor,’ making them the first team in ...
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
(Date:4/29/2016)... ... April 29, 2016 , ... For those who skip ... meal to miss. That was among the many new lifestyle diet tips offered by ... Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence noted that because ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... , April 29, 2016 ... H1 2016" market research report that provides an ... comparative analysis at various stages, therapeutics assessment by ... administration (RoA) and molecule type, along with latest ... also reviews key players involved in the therapeutic ...
(Date:4/29/2016)... -- Glycotope GmbH, a clinical-stage immuno-oncology company ... of Dr. Alfredo Zurlo as Chief Medical ... many years clinical experience and a proven track record ... was at Mologen AG where he was Chief Medical ... Zurlo held various positions at F Hoffmann La Roche ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s announced ... the company,s valve repair and stent business, healthcare ... places Abbott more firmly into patient monitoring.  Kalorama ... fastest growing device areas, with double-digit growth expected ... report,  Advanced Remote Patient Monitoring . ...
Breaking Medicine Technology: